Published Jun 12, 2019

Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development

Member News
Copy The Link to the  Article
Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development
Copy The Link to the  Article

Related or similar articles

View more News
July 16, 2025

A Different Take on Boston’s Biotech Future

Blog Posts
January 3, 2025

Exciting Equipment Additions to Labshares: Innovating Your Research

Labshares News
June 13, 2024

Advancing Science at Labshares: Diagonal Therapeutics' Journey

Labshares News